Jan 31, 2009 | 3
A pioneering medical journal has fallen victim to the dramatic and wrenching changes that are overtaking the publishing industry: The Medscape Journal of Medicine (MJM), the first electronic-only open access general medical journal,* will no longer publish new papers, Editor in Chief George Lundberg and colleagues announced yesterday.
Open access is a movement to make studies available for free online, instead of charging taxpayers who funded the research (and others) to read them. The first for-profit open access publisher, BioMed Central (BMC), was founded in 2000 and launched BMC Biochemistry, its first journal, in July of that year. A BMC parent company made articles in existing journals open access in 1999.** BMC was sold to Springer last year. The Public Library of Science (PLoS), the first nonprofit open-access publisher, was also founded in 2000, but did not publish its first journal, PLoS Biology, until October 2003.
Oct 7, 2008 | 2
Earlier this month, a free repository at Cornell University for technical papers that has become a wire service of sorts for physicists, mathematicians and other disciplines, named ArXiv, marked a major milestone as the number of papers collected there reached the half-million mark. ArXiv serves as the main forum for scientists in many fields to present and discuss the latest findings before their pre-publication papers are accepted by a journal.
An example: Grigori Perelman, who devised a proof for the Poincaré conjecture, a 100-year-old problem in mathematics, never submitted his solution to any academic journal. In 2002, he posted the first of a series of papers that contained a proof for the topology problem on ArXiv. Science magazine later named the work “breakthrough of the year” and Perelman was awarded the Fields Medal, the highest award in mathematics, which the quirky Russian refused.
Oct 7, 2008 | 1
Open access pioneer BioMed Central has been acquired by Springer, ScientificAmerican.com has learned.
Open access is the movement, recently bolstered by Congress, to make studies available for free online, instead of charging taxpayers who funded the research (and others) to read them. Many prominent scientists have backed it, signing on with BioMed Central and a non-profit open access publisher, the Public Library of Science.
BioMed Central publisher Matthew Cockerill announced the news in an email today to editors of BMC's journals.
Those in the open access movement had watched BioMed Central with keen interest. Founded in 2000, it was the first for-profit open access publisher and advocates feared that when the company was sold, its approach might change. But Cockerill assured editors that a BMC board of trustees "will continue to safeguard BioMed Central's open access policy in the future." Springer "has been notable...for its willingness to experiment with open access publishing," Cockerill said in a release circulated with the email to editors.
Deadline: Dec 11 2013
Reward: $52,000 USD
Platform technologies – tools, techniques, and instruments that enable entirely novel approaches for scientific investigation across a b
Deadline: Jan 27 2014
Reward: $15,000 USD
The Dow Chemical Company is the leading producer of polyalkylene glycols (PAGs) used in synthetic fluids and lubricants where petroleum,
Give a 1 year subscription as low as $14.99X